Vedolizumab for stricturing Crohn’s disease of the terminal ileum – an international multicenter cohort study

Abstract Objective Crohn’s disease (CD) frequently progresses to stricturing complications. Anti-stricture therapies are lacking, and anti-inflammatory therapies are hence the mainstay of medical treatment. However, data on the efficacy of vedolizumab in stricturing CD are not available. We therefor...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Sara El Ouali, Mark E. Baker, Cathy Lu, Alexandra Medellin, David H. Bruining, Joel G. Fletcher, Akitoshi Inoue, Miguel Regueiro, Ronald K. Ottichilo, Shayla Schoenoff, Ryan Rosentreter, James Bena, Taha Qazi, Stefan D. Holubar, Samantha Gauriloff, Namita S. Gandhi, Katherine Falloon, Joseph Sleiman, Benjamin L. Cohen, Idan Goren, Numan Balci, Florian Rieder, the Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2026-05-01
coleção:	BMC Gastroenterology
Assuntos:	Crohn’s disease Surgery Dilation Stricture Intervention Vedolizumab
Acesso em linha:	https://doi.org/10.1186/s12876-026-04815-4
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!